Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy.

Eljaszewicz, Andrzej; Ruchti, Fiorella; Radzikowska, Urszula; Globinska, Anna; Boonpiyathad, Tadech; Gschwend, Anna; Morita, Hideaki; Helbling, Arthur; Arasi, Stefania; Kahlert, Helga; Berek, Nadine; Nandy, Andreas; Akdis, Mübeccel; Willers, Christoph; Moniuszko, Marcin; Akdis, Cezmi A; Sokolowska, Milena (2021). Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy. Journal of allergy and clinical immunology, 147(5), pp. 1865-1877. Elsevier 10.1016/j.jaci.2020.08.042

[img]
Preview
Text
1-s2.0-S0091674920313968-main.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (2MB) | Preview

BACKGROUND

Despite the efficacy of allergen-specific immunotherapy (AIT), the role of trained immunity and tolerance in this process has not been elucidated.

OBJECTIVE

Here, we have performed a comprehensive longitudinal analysis of the systemic innate immune cell repertoire during the course of AIT.

METHODS

Patients with allergy received standard preseasonal subcutaneous AIT with allergoids to birch and/or grass. Healthy controls were monitored without any intervention. Flow cytometry of innate lymphoid cell (ILC), natural killer cell, monocyte cell, and dendritic cell (DC) subsets was performed at baseline, 3 months (birch season), 6 months (grass seasons), and 12 months after the therapy in patients or at similar seasonal time points in controls. Additional analyses were performed in the third-year birch and grass season.

RESULTS

We observed a durable decrease in group 2 ILCs and an increase of group 1 ILCs after AIT, with dynamic changes in their composition. We found that an expansion of CD127+CD25++ clusters caused observed shifts in the heterogeneity of group 1 ILCs. In addition, we observed development of CD127+CD25++c-Kit+ group 3 ILC clusters. Moreover, we found an increase in the number of intermediate monocytes in parallel with a reduction in nonclassical monocytes during the first year after AIT. Classical and intermediate monocytes presented significant heterogeneity in patients with allergy, but AIT reduced the HLA-DR++ clusters. Finally, an increase in plasmacytoid DCs and CD141+ myeloid DCs was observed in individuals with allergy, whereas the number of CD1c+ myeloid DCs was reduced during the first year of AIT.

CONCLUSION

AIT induces changes in the composition and heterogeneity of circulating innate immune cells and brings them to the level observed in healthy individuals. Monitoring of ILCs, monocytes, and DCs during AIT might serve as a novel biomarker strategy.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology

UniBE Contributor:

Gschwend, Anna and Helbling, Arthur

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1097-6825

Publisher:

Elsevier

Language:

English

Submitter:

Heidi Lobsiger

Date Deposited:

20 Jul 2021 10:30

Last Modified:

20 Jul 2021 10:37

Publisher DOI:

10.1016/j.jaci.2020.08.042

PubMed ID:

33039478

Uncontrolled Keywords:

Allergen immunotherapy DCs ILC NK cells antigen-presenting cells innate immune cells monocytes

BORIS DOI:

10.48350/157626

URI:

https://boris.unibe.ch/id/eprint/157626

Actions (login required)

Edit item Edit item
Provide Feedback